Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
Clinical trial NCT04451837 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04451837
- Sponsor
- Region Skane
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2021-12-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.